The PathoSense Dx assay using nanopore sequencing is available via these frontline veterinary diagnostic laboratories.
Complete veterinary diagnostics of infectious diseases and applied microbial genomics
Frontline innovation to advance animal health
PathoSense is a spin-off company from Ghent University. We're dedicated to making genomic solutions easily accessible and actionable for veterinary and biotech industries.
CO-FOUNDERS DR. SEBASTIAAN THEUNS AND PROF. HANS NAUWYNCK
Our expertise and services
PathoSense Dx for vets
PathoSense developed a complete sample-collection-to-diagnostic-interpretation platform for infectious diseases in veterinary medicine. Using nanopore sequencing, PathoSense can detect all viruses and bacteria without prior selection in all animal species. This will bring the veterinary insights and advice to a higher level.
PathoSense Dx for partnerlabs
PathoSense is partnering with frontline veterinary diagnostic labs that are eager to expand their diagnostic portfolio with this powerful tool. Partnering with PathoSense enables implementing nanopore sequencing in a cost-effective and an easy way. Join us to provide an expanded service level to your veterinary customers.
Microbiome
Pathosense offers comprehensive analyses of bacterial communities to get insights in the microbiome. Our services are accessible for a wide variety of applications from animal & human nutrition to environmental research. We stand out in our human touch during the guidance from study design to data interpretation.
Pathogen WGS
PathoSense specializes in whole-genome sequencing of micro-organisms (viruses, bacteria & yeasts). Our fast and cost-effective service encompasses nucleic acid extraction, long-read sequencing, expert bioinformatics analysis, and thorough reporting.
Partner labs
Trusted by
PathoSense proudly collaborates with leading companies and institutions across various fields for diagnostics, microbiome research and pathogen whole genome sequencing. Together, we advance scientific research and improve outcomes in the animal nutrition, pharmaceutical and biotech industries.
